Nursing Open launches!

Nursing Open launch cover

Wiley is delighted to announce the launch of its newest open access journal, Nursing Open, the first open access journal to publish high-quality articles covering all aspects of nursing, from education and research through to policy and practice.

Editor Roger Watson was present at the launch which took place at the prestigious Royal College of Nursing’s International Research Conference last week.  Professor Watson is based at the University of Hull and has extensive experience working with older people, and in particular the feeding and nutritional problems faced by patients with dementia.

“Nursing Open aims to provide integrity and speed in publishing a wide range of high quality nursing scholarship and, within a short time, to be the preferred destination for open access articles in nursing.” said Professor Watson.

In what could be one of the most important launches in the nursing field for years, Nursing Open aims to have a positive impact on health, from local and regional to national and global scales.  The journal provides authors with a new platform for the rapid dissemination of research on nursing and midwifery practice, and will make a real and valuable contribution towards the science of nursing. The journal will publish articles under the Creative Commons Attribution (CC BY) License, allowing authors to comply with Open Access Mandates.

Nursing Open is now open for submissions. For more information on the journal, including how to submit an article, please visit the website at: www.nursingopenjournal.com

Molecular Genetics & Genomic Medicine Volume 2 Issue 2 is Published!

MGGM Molecular Genetics & Genomic Medicine has now published its next issue. Editor-in-Chief: Max Muenke introduces his editorial highlights: “This issue includes an Invited Commentary on newborn screening, along with articles on association of the GPR88 gene and major psychoses and TNNT1 mutations in nemaline myopathy.  It also features the first article in our series Genetics and Genomic Medicine around the World, this month focusing on Israel.  Highlights of the issue include ‘Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia’ and ‘Analysis of PRICKLE1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations.

Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia by Anas M. Alazami, Mohammed Zain Seidahmed, Fatema Alzahrani, Adam O. Mohammed and Fowzan S. Alkuraya. Abstract: Cranioectodermal dysplasia (CED) is a very rare autosomal recessive disorder characterized by a recognizable craniofacial profile in addition to ectodermal manifestations involving the skin, hair, and teeth. Four genes are known to be mutated in this disorder, all involved in the ciliary intraflagellar transport confirming that CED is a ciliopathy. In a multiplex consanguineous family with typical CED features in addition to intellectual disability and severe cutis laxa, we used autozygosity-guided candidate gene analysis to identify a novel homozygous mutation in IFT122, and demonstrated impaired ciliogenesis in patient fibroblasts. This report on IFT122 broadens the phenotype of CED and expands its allelic heterogeneity.

Analysis of PRICKLE1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations by Tian Yang, Zhonglin Jia, Whitney Bryant-Pike, Anand Chandrasekhar, Jeffrey C. Murray, Bernd Fritzsch and Alexander G. Bassuk. Abstract: Palate development is shaped by multiple molecular signaling pathways, including the Wnt pathway. In mice and humans, mutations in both the canonical and noncanonical arms of the Wnt pathway manifest as cleft palate, one of the most common human birth defects. Our results reveal that in mice and humans PRICKLE1 directs palate morphogenesis; our results also uncouple Prickle1 function from Vangl2 function. Together, these findings suggest mouse and human palate development is guided by PCP-Prickle1 signaling that is probably not downstream of Vangl2. 

The journal also publishes Genetics and Genomic Medicine around the World. Below is the first article of this type, this month focusing on Israel.
Genetics and genomic medicine in Israel” by Joël Zlotogora

Ensure you don’t miss any articles. Sign up to receive email alerts here.

Submit your article here.

Molecular Genetics & Genomic Medicine Volume 2 Issue 2 is Published!

MGGM Molecular Genetics & Genomic Medicine has now published its next issue. Editor-in-Chief: Max Muenke introduces his editorial highlights: “This issue includes an Invited Commentary on newborn screening, along with articles on association of the GPR88 gene and major psychoses and TNNT1 mutations in nemaline myopathy.  It also features the first article in our series Genetics and Genomic Medicine around the World, this month focusing on Israel.  Highlights of the issue include ‘Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia’ and ‘Analysis of PRICKLE1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations.

Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia by Anas M. Alazami, Mohammed Zain Seidahmed, Fatema Alzahrani, Adam O. Mohammed and Fowzan S. Alkuraya. Abstract: Cranioectodermal dysplasia (CED) is a very rare autosomal recessive disorder characterized by a recognizable craniofacial profile in addition to ectodermal manifestations involving the skin, hair, and teeth. Four genes are known to be mutated in this disorder, all involved in the ciliary intraflagellar transport confirming that CED is a ciliopathy. In a multiplex consanguineous family with typical CED features in addition to intellectual disability and severe cutis laxa, we used autozygosity-guided candidate gene analysis to identify a novel homozygous mutation in IFT122, and demonstrated impaired ciliogenesis in patient fibroblasts. This report on IFT122 broadens the phenotype of CED and expands its allelic heterogeneity.

Analysis of PRICKLE1 in human cleft palate and mouse development demonstrates rare and common variants involved in human malformations by Tian Yang, Zhonglin Jia, Whitney Bryant-Pike, Anand Chandrasekhar, Jeffrey C. Murray, Bernd Fritzsch and Alexander G. Bassuk. Abstract: Palate development is shaped by multiple molecular signaling pathways, including the Wnt pathway. In mice and humans, mutations in both the canonical and noncanonical arms of the Wnt pathway manifest as cleft palate, one of the most common human birth defects. Our results reveal that in mice and humans PRICKLE1 directs palate morphogenesis; our results also uncouple Prickle1 function from Vangl2 function. Together, these findings suggest mouse and human palate development is guided by PCP-Prickle1 signaling that is probably not downstream of Vangl2. 

The journal also publishes Genetics and Genomic Medicine around the World. Below is the first article of this type, this month focusing on Israel.
Genetics and genomic medicine in Israel” by Joël Zlotogora

Ensure you don’t miss any articles. Sign up to receive email alerts here.

Submit your article here.

Onwards and Upwards for Wiley Open Access

2013 was quite a year for Wiley Open Access, with the addition of 16 new open access journals to our portfolio,  OnlineOpen orders reaching an all time high and the significant increase in institutions with Wiley Open Access Accounts.

2014 is also set to be a year of growth. Wiley will be publishing 33 journals as part of the Wiley Open Access program, many in partnership with societies.  In addition, over 1,300 of our subscription journals now offer the hybrid Online Open option to authors. We have recently launched or are planning to launch the following new Open Access journals:

In addition, the following journals ’flipped’  from the subscription model to Open Access on 1st January 2014:

The complete list of 2014 Journal Titles, Changes and Collections is available on Wiley Online Library.

Molecular Genetics & Genomic Medicine Volume 2 Issue 1 is Published!

MGGM Molecular Genetics & Genomic Medicine has now published its next issue. Editor-in-Chief: Max Muenke introduces his editorial highlights: “Our second volume continues with the high-quality manuscripts that you have come to expect, with articles on Usher syndrome exome sequencing, identification of novel mutations in Donohue syndrome, and a revision of the mitochondrial tRNA pathogenicity scoring system.  In addition, we announce a new feature, “Genetics and Genomic Medicine around the World”.   Highlights of the first issue of Volume 2 include “Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster disease, infantile mitochondrial complex II/III deficiency” and “Candidate disease gene prediction using Gentrepid: application to a genome-wide association study on coronary artery disease”.

Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster disease, infantile mitochondrial complex II/III deficiency by Sali M. K. Farhan, Jian Wang, John F. Robinson, Piya Lahiry, Victoria M. Siu, Chitra Prasad, Jonathan B. Kronick, David A. Ramsay, C. Anthony Rupar and Robert A. Hegele. Summary: We describe infantile mitochondrial complex II/III deficiency, a novel autosomal recessive mitochondrial disease characterized by lactic acidemia, hypotonia, respiratory chain complex II and III deficiency, multisystem organ failure, and abnormal mitochondria. Through autozygosity mapping, exome sequencing, in silico analyses, population studies, and functional tests, we identified c.215G>A, p.Arg72Gln in NFS1 as the likely causative mutation. We describe the first disease in man likely caused by deficiency in NFS1, a cysteine desulfurase that is implicated in respiratory chain function and iron maintenance by initiating Fe-S cluster biosynthesis.

Candidate disease gene prediction using Gentrepid: application to a genome-wide association study on coronary artery disease by Sara Ballouz, Jason Y. Liu, Martin Oti, Bruno Gaeta, Diane Fatkin, Melanie Bahlo and Merridee A. Wouters. Summary: The application of a candidate disease gene prediction tool to a genome-wide association study on coronary artery disease revealed numerous novel candidates. The method and results of this analysis using protein networks and protein functional domains are presented here, along with the candidates.

The journal now also publishes the new feature Genetics and Genomic Medicine around the World. Below is the editorial explaining this new feature:
Genetics and Genomic Medicine around the World” by Maximilian Muenke

Ensure you don’t miss any articles. Sign up to receive email alerts here.

Submit your article here.

Read the inaugural issue of Pharmacology Research & Perspectives

53417-PRP-journalWe are pleased to announce that Pharmacology Research & Perspectives has now published its inaugural issue. Pharmacology Research & Perspectives is a new journal from the British Pharmacological Society (BPS) and the American Society for Pharmacology & Experimental Therapeutics (ASPET) and promotes research in all areas of pharmacology.   
 
The editor’s choice articles from the inaugural issue are:  
  
purple_lock_openGreen fluorescent protein fused to peptide agonists of two dissimilar G protein-coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor
Xavier Charest-Morin, Jean-Philippe Fortin, Marie-Thérèse Bawolak, Robert Lodge and François Marceau    

purple_lock_openEffects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo
Seth C. Hopkins, Una C. Campbell, Michele L. R. Heffernan, Kerry L. Spear, Ross D. Jeggo, David C. Spanswick, Mark A. Varney and Thomas H. Large    

purple_lock_open Cilostazol prevents retinal ischemic damage partly via inhibition of tumor necrosis factor-?-induced nuclear factor-kappa B/activator protein-1 signaling pathway
Fumiya Ishizuka, Masamitsu Shimazawa, Yusuke Egashira, Hiromi Ogishima, Shinsuke Nakamura, Kazuhiro Tsuruma and Hideaki Hara
 

Read inaugural issue

 Pharmacology Research & Perspectives invites authors to submit research articles and invites submission of several types of special articles. These are:
1. Target validation – publication of negative findings including preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development
2. Drug discovery reviews – strategy, hypotheses and data resulting in a successful therapeutic drug
3. Frontiers in translational medicine – drug and target validation for an unmet therapeutic need
4. Pharmacological hypotheses – reviews that are oriented to inform a novel hypothesis

All articles are published under a Creative Commons License and comply with all open access mandates.

PRP2

Physiological Reports Publishes Issue 1.6

Physiological ReportsThe latest issue of Physiological Reports has now closed. A collaboration between The Physiological Society and the American Physiological Society, the journal offers the highest quality peer review and is proudly open access.

Below are the ‘Editor’s Choice’ articles for this issue:

purple_lock_open Inhibitory collaterals in genetically identified medium spiny neurons in mouse primary corticostriatal cultures
Rupa R. Lalchandani and Stefano Vicini
Summary: D1 and D2 MSNs extend inhibitory collaterals that shape neuron firing and striatal output. Using BAC transgenics and paired whole-cell recordings, we describe a paradigm that allows for the simultaneous identification of both MSN subtypes and the targeted study of MSN collaterals.

purple_lock_open Cardiac power integral: a new method for monitoring cardiovascular performance
Audun E. Rimehaug, Oddveig Lyng, Dag O. Nordhaug, Lasse Løvstakken, Petter Aadahl and Idar Kirkeby-Garstad
Summary: The continuous product of aortic flow and aortic pressure is the cardiac power curve. The time integral of this curve is the cardiac power integral, and represents the energy transferred from the heart to the aorta. Using a porcine model, we have validated a system for acquiring the cardiac power integral, and found a strong correlation between the cardiac power integral and stroke work across multiple different loading and contractility conditions.

purple_lock_open Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-?-d-glucoside in rats
Aaron Hoffman, Marina Okun-Gurevich, Elena Ovcharenko, Ilia Goltsman, Tony Karram, Cristopher Cain, Zaid Abassi and Joseph Winaver
Summary:
Xanthurenic glucoside is a new endogenous mild natriuretic/diuretic agent acting on amiloride-sensitive renal epithelial sodium channels. In addition, the in vivo natriuretic effects are partially mediated by NO-dependent mechanisms.

purple_lock_open Vascular effects of deletion of melanocortin-4 receptors in rats
David W. Stepp, Christabell C. Osakwe, Eric J. Belin de Chantemele and James D. Mintz
Summary:
Obesity causes hypertension, but links remain incompletely understood. Prior studies have suggested that metabolic signals that target melanocortin-4 receptors (MC4R)-expressing neurons in the brain play an important role in linking weight gain to blood pressure. In this study, we demonstrate that in rats genetically devoid of MC4R receptors, morbid obesity fails to produce increases in blood pressure, providing further evidence that MC4R are an important link between increased weight and hypertension.

The journal recently published its 100th article. Find out more about the first 100 articles here.

You can submit your article to Physiological Reports using the online submission site. We look forward to hearing from you soon.

International Open Access Week: Wiley’s participation

oaweekLast week (Oct 21-25) was International Open Access Week.  We spent the week particpating in discussion and sharing information. In cased you  missed anything, here is a summary of our week.

The results of  Wiley’s open access survey of 8000+ authors were published.  You can read a summary of the results on our Exchanges blog site.

We created a data visualization tool so that users can drill into the data by research experience, region, and subject area.

We also produced this infographic which shows key results from our author survey alongside OA results from our librarian survey (conducted in May) as well as Wiley’s own experiences of where authors who choose to publish OA are coming from.

We wrote about the effect that funder mandates are having on the take-up of Wiley’s OA offerings.

Also, during this International Open Access week, we announced the transition of four leading journals from the subscription model to Gold OA from January 2014, bringing the total number of Wiley’s open access titles to 28.

You can also read a comment here from Helen Bray about the role of open communications from publishers in the open science movement.

More about Wiley Open Access can be found on this blog, or here: http://www.wileyopenaccess.com/.  And lastly, don’t forget you can follow us at www.facebook.com/wileyopenaccess or tweet us at  @WileyOpenAccess

Opening up our open access survey data

We’ve been really pleased with the response to our author survey on open access.  Now, you can get your hands on some of the data with our interactive visualization tool, and find out how open access authors vary by research experience, region, and subject area.  Later on this week we’ll be featuring some more results from the survey and showing how author and librarian experiences compare.

We also have a short poll on the Wiley Exchanges blog – we’d love to know if your experience matches the results of the survey.

 In the meantime, we hope you enjoy our data!

data vizualisation

 

Generational differences in authors’ open access views and experience: 2013 Wiley Open Access survey results

We have just announced the results of our 2013 author survey  on open access, with over 8,000 respondents from across Wiley’s journal portfolio. 

The growth in open access publishing is clearly evident: the number of respondents who have published an open access article is double that in our 2012 open access survey , and authors are reporting a larger percentage of research funding to publish open access compared with last year.

The desire of authors to publish in high-quality, respected journals with a good Impact Factor remains consistent with our 2012 survey findings. However, the 2013 survey sheds new light on differences between early career researchers and more established colleagues in their opinions on quality and licenses, and the funding available to them.

The differences revealed between early career researchers and more experienced academics emphasize the importance of offering authors a range of open access options. Protecting author choice, and the continued cooperation between publishers, funders, and institutions to make open access publishing easier for those who want it is crucial for the continued development of the OA field. 

To view the results in more detail, view the full announcement here.

Energy Science & Engineering first issue now live!

ESE coverWe are delighted to announce that Energy Science & Engineering has published its inaugural issue.

Since opening for submission in October 2012, Energy Science & Engineering has received high quality of papers across the field of energy research. Published in collaboration with SCI (Society of Chemical Industry), ESE is a peer reviewed, open access journal dedicated to fundamental and applied research on energy supply and use. Priority is given to quality research papers that are accessible to a broad readership and discuss sustainable, state-of-the art approaches to shaping the future of energy.

Read all our open access articles online here

purple_lock_open  Biodiesel from Grease Interceptor to Gas-Tank
Alyse Mary E. Ragauskas, Yunqiao Pu, Art J. Ragauskas
Summary: The need for sustainable biofuels has initiated a global search for innovative technologies that can sustainably convert nonfood bioresources to liquid transportation fuels. While 2nd generation cellulosic ethanol has begun to address this challenge, other resources including yellow and brown grease are rapidly evolving commercial opportunities that are addressing regional biodiesel needs. This review examines the technical and environmental factors driving the collection of trap FOG (Fats, Oils, and Greases), its chemical composition and technologies currently available and future developments that facilitate the conversion of FOG into biodiesel.

purple_lock_open  Next generation biorefineries will solve the food, biofuels, and environmental trilemma in the energy–food–water nexus
Y.-H Percival Zhang
Summary: The future roles of biomass and carbohydrate for meeting needs of food/feed, renewable materials, and transportation fuels (biofuels) remain controversial due to numerous issues, such as increasing food and feed needs, constraints of natural resources (land, water, phosphate, biomass, etc.), and limitations of natural photosynthesis, as well as competing energy conversion pathways and technologies. The goal of this opinion article is to clarify the future roles of biomass and biorefineries using quantitative data other than adjective words

purple_lock_open  Lock-in thermography as a tool for quality control of photovoltaic modules
Andreas Vetter, Frank Fecher, Jens Adams, Raymund Schaeffler, Jean-Patrick Theisen, Christoph J. Brabec and Claudia Buerhop
Summary: In this short communication, we present a method which utilizes contactless ILIT (illuminated lock-in thermography) measurement of a photovoltaic (PV) module and image postprocessing in order to calculate the peak power Pmpp of the module and to study the influence of local defects on the module performance. In total, 103 Copper-Indium-Gallium-Diselenide (CIGS) modules were investigated and the results showed a good correlation (mean error less than 6%) between the calculated IR-signal and the measured Pmpp. We performed our study on CIGS modules but the presented approach is not restricted to CIGS modules. The method provides a valuable tool for PV quality control.

Enjoy reading the first issue! Submit your paper here> Sign-up for eToc alerts here>

Wiley Journals comply with new open access policies of UK funders

The majority of Wiley’s journals in its open access publishing program now offers authors funded by The Wellcome Trust and Research Councils UK the opportunity to publish their articles under a Creative Commons Attribution CC BY license when paying an Article Publication Charge (APC).  This now supports authors in complying with funder requirements that came into place 1 April 2013. The CC BY license allows others to modify, build upon and/or distribute the licensed work (including for commercial purposes) as long as the original author is credited.  

“Enabling RCUK and Wellcome Trust funded researchers to continue publishing in the journals of their choice is very important to us,” said Rachel Burley, Vice President and Director, Open Access. “Wiley is a strong supporter of sustainable open access and is committed to meeting the needs of authors and their research funders.”

Wiley has also updated its self-archiving policy for RCUK authors. If an author funded by RCUK chooses to publish in a Wiley journal but doesn’t select and pay for OnlineOpen they will be able to self-archive the accepted version of the article after a 12 month embargo period (starting with first publication online), or after a 24 month embargo for authors funded by the Arts and Humanities Research Council (AHRC) and the Economic and Social Research Council (ESRC). If a journal does not offer an open access option the embargo period is reduced to 6 months (RCUK’s STM Councils) or 12 months for authors funded by AHRC and ESRC. 

A limited number of society owned journals have not adopted the new self-archiving policy and/or the new OnlineOpen license policy and will continue to publish under the usual journal copyright license terms. 

Read more on Wiley’s open access policies here.

RCUK – funded authors can watch our video to get details of the applicable open access policies and how to comply when publishng with Wiley’s OnlineOpen program:

Darrell Abernethy MD, PhD appointed as Deputy Editor of Pharmacology Research & Perspectives (PR&P)

Abernethy_Darrell_cropped We are delighted to announce the appointment of Darrell Abernethy as Deputy Editor of Pharmacology Research & Perspectives (PR&P).  Darrell joins Editor-in-Chief, Michael J. Curtis of King’s College London, to direct the new open access, peer-reviewed journal that will open for submissions in April 2013. Dr. Abernethy’s faculty appointment is with the Johns Hopkins University School of Medicine. He received his M.D. (AOA) and Ph.D. (Pharmacology) degrees from the University of Kansas School of Medicine. Dr. Abernethy is an experienced editor. He served as Editor-in-Chief of Pharmacological Reviews and as an Associate Editor of the Journal of Pharmacology and Experimental Therapeutics among other positions. He has contributed to the understanding of mechanisms of peripheral distribution of drugs and drug disposition and effect in obesity. He is currently developing a pharmacology mechanism-based drug safety prediction program based on systems pharmacology.

prp_cover_final.indd PR&P will be published in partnership with Wiley, The American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS).  PR&P will publish original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, therapeutics, education and related research areas.  More information regarding the new journal can be read here.

Physiological Reports, new open access journal, is open for submissions

Physiological ReportsPhysiological Reports is now open for submissions, the first 100 articles accepted for publication will be published free of charge.  Susan Wray, Editor-in-Chief and Thomas Kleyman, Deputy Editor-in-Chief  lead the Editorial Board for the new online only, open access journal.  The journal will publish peer-reviewed research across all areas of basic, translational and clinical physiology and allied disciplines. Physiological Reports is a collaboration between The Physiological Society and the American Physiological Society, and is therefore in a unique position to serve the international physiology community through quick time to publication while upholding a quality standard of sound research that constitutes a useful contribution to the field.

The journal offers:

  • High standard, rigorous peer review
  • Rapid time from submission to decision
  • Rapid time from decision to publication
  •  ”Article by article publication” – no delay in waiting for the issue to close
  • Open Access – published articles are licensed under Creative Commons Attribution (CC BY), and authors are the copyright holders
  • Compliant with open access mandates
  • Wide dissemination
  • Promotion of, and publicity for quality research

Submit a manuscript >

ASPET and BPS Partner With Wiley To Launch Open Access Journal Pharmacology Research & Perspectives

prp_cover_final.inddThe American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) announced today their partnership to publish the new open access, peer-reviewed journal, Pharmacology Research & Perspectives, which will open for submissions in April 2013. Michael J. Curtis of King’s College London, UK has been appointed as Editor-in-Chief of this new journal.

Pharmacology Research & Perspectives (PR&P) will publish original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, therapeutics, education and related research areas.  The journal will serve as the first fully open access journal for ASPET and BPS, and joins their combined portfolio of prestigious peer-reviewed subscription-based scientific journals, such as the Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology, British Journal of Pharmacology, and British Journal of Clinical Pharmacology.

MJC bestEditor-in-Chief Dr. Michael J. Curtis obtained his PhD from the University of British Columbia and has been a Reader at King’s College London since 1996. Dr Curtis has extensive editorial experience, serving as Editor-in-Chief of the Journal of Pharmacological and Toxicological Methods and Reviews Editor of British Journal of Pharmacology, among other positions.

“The publication of Pharmacology Research & Perspectives puts the ASPET-BPS-Wiley alliance at the forefront of open access publishing in pharmacology. I am confident that Mike’s expertise and insight will ensure we are able to realise the full potential of this exciting opportunity,” said Professor Philip Routledge, BPS President.

“ASPET is pleased to be working with the British Pharmacological Society and Wiley to launch this exciting new open access journal.  The journal builds on the long-standing excellence of the publications associated with the two scientific societies and we join enthusiastically with Wiley in this new endeavor that will provide additional options for scientists and a forum for new directions in the discipline of pharmacology,” commented James E. Barrett, Chair of ASPET’s Board of Publications Trustees.

Deborah Dixon, VP, Publishing Director, Wiley, added, “We are extremely pleased to be partnering with two prestigious organizations to publish this new open access journal in pharmacology. It will provide authors worldwide with a high quality publishing option that will be fast and efficient.”

All articles in PR&P will be published as fully open access under a Creative Commons License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.

 The journal expects to publish its first issue in autumn 2013.